Skip to content
  • TearSolutions, Inc.
  • Phase 2 Clinical Trial
  • Mission
  • Team
  • Questions

TearSolutions, Inc.

Phase 2 Trial Screening Now Complete
Natural therapy for dry eye

Welcome

Human tears supply and protect the surface of the eye. Several tear proteins are deficient in dry eye, the most common eye disease. One is essential and when reintroduced to dry eye tears, health is restored. Lacripep™ is a first-in-class topical synthetic peptide treatment for dry eye that addresses cause.

 

Share this:

  • Click to print (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on Twitter (Opens in new window)

footer

About This Site

TearSolutions, Inc is a Charlottesville, Virginia drug development company incorporated in Delaware.

 

Find Us

TearSolutions, Inc.
315 Old Ivy Way, Suite 301
Charlottesville, Virginia 22903

Contact:

TearSolutions CFO Colin Rolph: crolph@tearsolutions.com

434-951-0444

 

  • Facebook
  • LinkedIn
Proudly powered by WordPress | Theme: Aaron by Carolina